EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism

Ruwen Böhm, Henrike Bruckmueller iD, Stefan Oswald iD, Matthias Hübenthal iD, Meike Kaehler iD, Lena Ehmke, Jan Höcker, Werner Siegmund iD, Andre Franke, Ingolf Cascorbi iD

Clinical Pharmacology & Therapeutics · 2024

DOI: 10.1002/cpt.3270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Pharmacology & Therapeutics, 2024. Verfasst von Ruwen Böhm und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany. Hauptthemen laut MEDLINE: Phenotype, Polymorphism, Single Nucleotide, Genotype. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although great progress has been made in the fine‐tuning of diplotypes, there is still a need to further improve the predictability of individual phenotypes of pharmacogenetically relevant enzymes. The aim of this study was to analyze the additional contribution of sex and variants identified by exome chip analysis to the metabolic ratio of five probe drugs. A cocktail study applying dextromethorphan, losartan, omeprazole, midazolam, and caffeine was conducted on 200 healthy volunteers. CYP2D6, 2C9, 2C19, 3A4/5, and 1A2 genotypes were analyzed and correlated with metabolic ratios. In addition, an exome chip analysis was performed. These SNPs correlating with metabolic ratios were confirmed by individual genotyping. The contribution of various factors to metabolic ratios was assessed by multiple regression analysis. Genotypically predicted phenotypes defined by CPIC discriminated very well the log metabolic ratios with the exception of caffeine. There were minor sex differences in the activity of CYP2C9, 2C19, 1A2, and CYP3A4/5. For dextromethorphan (CYP2D6), IP6K2 (rs61740999) and TCF20 (rs5758651) affected metabolic ratios, but only IP6K2 remained significant after multiple regression analysis. For losartan (CYP2C9), FBXW12 (rs17080138), ZNF703 (rs79707182), and SLC17A4 (rs11754288) together with CYP diplotypes, and sex explained 50% of interindividual variability. For omeprazole (CYP2C19), no significant influence of CYP2C:TG haplotypes was observed, but CYP2C19 rs12777823 improved the predictability. The comprehensive genetic analysis and inclusion of sex in a multiple regression model significantly improved the explanation of variability of metabolic ratios, resulting in further improvement of algorithms for the prediction of individual phenotypes of drug‐metabolizing enzymes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhenotypePolymorphism, Single NucleotideGenotypeHumansMaleFemaleAdultExomeCaffeineDextromethorphanLosartanPharmaceutical PreparationsYoung AdultOmeprazoleSex FactorsCytochrome P-450 Enzyme SystemGenetic Association StudiesOligonucleotide Array Sequence Analysis

Substanzen

CaffeineDextromethorphanLosartanPharmaceutical PreparationsOmeprazoleCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Institute of Experimental and Clinical Pharmacology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.
  • Institute of Pharmacology and Toxicology, Rostock University Medical Center, Rostock, Germany.
  • Department of Dermatology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Department of Anesthesiology, Surgical Intensive Care and Palliative Medicine, Friedrich-Ebert-Krankenhaus, Neumünster, Germany.
  • Department of Clinical Pharmacology, University Hospital Greifswald, Greifswald, Germany.

ORCID-Profile: Henrike Bruckmueller, Stefan Oswald, Matthias Hübenthal, Meike Kaehler, Werner Siegmund, Ingolf Cascorbi

Zitieren

APA

Böhm, R., Bruckmueller, H., Oswald, S., Hübenthal, M., Kaehler, M., Ehmke, L., Höcker, J., Siegmund, W., Franke, A., & Cascorbi, I. (2024). Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical Pharmacology & Therapeutics. https://doi.org/10.1002/cpt.3270

Vancouver

Böhm R, Bruckmueller H, Oswald S, Hübenthal M, Kaehler M, Ehmke L, et al. Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism. Clinical Pharmacology & Therapeutics. 2024. doi:10.1002/cpt.3270

BibTeX
@article{Bhm2024,
  author = {Böhm, Ruwen and Bruckmueller, Henrike and Oswald, Stefan and Hübenthal, Matthias and Kaehler, Meike and Ehmke, Lena and Höcker, Jan and Siegmund, Werner and Franke, Andre and Cascorbi, Ingolf},
  title = {Phenotype–Genotype Correlation Applying a Cocktail Approach and an Exome Chip Analysis Reveals Further Variants Contributing to Variation of Drug Metabolism},
  journal = {Clinical Pharmacology & Therapeutics},
  year = {2024},
  doi = {10.1002/cpt.3270}
}
Kostenlos starten →